Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Apple

Alphabet

Microsoft

Visa

Here are five stocks to consider in the new bull market: Microsoft, Apple, UnitedHealth Group, Visa, and Alphabet. These companies generally have strong net cash positions, significant free cash flow, and the potential for substantial growth. They are key components within the stylistic area of large cap growth. We like these ideas, including big cap tech and large cap growth, much more than high yield equities such as mortgage REITs and master limited partnerships.

5 Stocks For A New Bull Market

MSCI

Primerica

Tractor Supply

High dividend-growth stocks are ones raising their payout at a double-digit rate. These companies typically only started paying a dividend recently.

4 High Dividend-Growth Stocks

Amgen

Caterpillar

Salesforce

Goldman Sachs

Home Depot

Intel

Johnson & Johnson

JPMorgan Chase & Co

The Dow's 10-straight day rally keeps making history — it hasn't done this since at least 2017. And investors can thank a select group.

11 Stocks Drive The Dow's Amazing 10-Straight Day Rally

SPDR Dow Jones Industrial Average ETF

Since last week, the Dow Jones index has been performing very well. The index jumped more than 150 points yesterday to log its first nine-day rally since 2017, per a CNBC article.

Stocks in Focus on Dow Jones ETF's First 9-Day Run Since 2017

Eli Lilly

Eli Lilly and UnitedHealth Group have market caps in excess of $400 billion. Promising weight-loss treatments could generate significant growth for Eli Lilly.

2 Healthcare Stocks That Could Join the $1 Trillion Club by 2033

Target

UnitedHealth Group's stock slid this year amid concerns about a rise in surgeries. Target's stock nosedived since the summer as controversial merchandising decisions led to calls for boycotts.

Got $5,000? These 2 Growth Stocks Are Trading Near Their 52-Week Lows

Markets jumped again on Tuesday. Microsoft climbed as it released several AI-linked initiatives.

These 2 Dow Stocks Led the Market Higher Tuesday

The health insurer's stock won a recommendation upgrade from an analyst. This came on the heels of its latest earnings report.

Why UnitedHealth Stock Shot Higher on Tuesday

UnitedHealth Group's revenue and earnings roared higher in its second quarter. The company's dividend is primed to continue growing at a strong rate.

Should You Buy This Dividend-Growth Machine for Your Portfolio?

iShares U.S. Healthcare ETF

Harbor Health Care ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

UnitedHealth (UNH) reported better-than-expected second-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues. The company lifted the lower end of its full-year earnings guidance.

UnitedHealth Beats Q2 Earnings, Updates View: ETFs to Gain

The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation rates in the nation, rising interest rates are having the subsequent effect of slowing down the prospects for businesses inherently dependent on the business cycle.

United Health Stock Is Flying, It May Only Be The Beginning

Direxion Daily Healthcare Bull 3x Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

SPDR S&P 500 ETF Trust

Direxion Daily Technology Bull 3x Shares

Direxion Daily 20+ Year Treasury Bull 3X Shares

Invesco DB US Dollar Index Bullish Fund

Direxion Daily FTSE China Bear 3X Shares

Direxion Daily FTSE China Bull 3X Shares

This article highlights current and future ETF/ETN breakouts for Week 29 using the MDA momentum cycle model. Following the positive Momentum Gauge signal on June 1st, leading funds include NAIL +67.1%, FNGU +27.5%, TNA +26.5%, BNKU +20.5%, SPXL +19.5%, FAS +19.4%. Healthcare remains the only sector negative for the past month, and the beat by UnitedHealth Group may lead to a breakout in Healthcare fund CURE.

July Breakout ETF/ETNs Week 29 - 2023: Strongest Momentum Gainers For Next Week

Asana

Axonics ModulationTechnologies Inc

Butterfly Network

Celsius Holdings

Cisco Systems

D.R. Horton

Enphase Energy

Jiayin Group Inc - ADR

Coca-Cola

NIKE

Procter & Gamble

Super Micro Computer

Two new Breakout Stocks for Week 29 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are at +126.4% YTD. Last week 3 out of 4 picks gained over 13.4% with peak gains in KODK +23.8%, SMCI +19.2%, YMM +13.4%. The S&P 500 gained +2.4%. The streak of weekly picks gaining over 10% in less than a week has reached 254 out of 320 trading weeks (79.3%) not considering multiple gainers or negative MG signals.

July MDA Breakout Stocks Week 29 - 2023: High-Frequency Gainers To Give You An Edge

CVS Health

America's national health expenditure reached $4.3 trillion in 2021, and it's expected to continue rising by 5.4% annually through 2031. CVS Health is famous for pharmacies, but it also runs Aetna, a health insurance benefits management business.

2 Exceptional Dividend Growth Stocks to Buy Near 52-Week Lows

Abbott Labs

Elevance Health Inc

Intercontinental Exchange

Thermo Fisher Scientific

Toro

The article presents a monthly series of 10 top-ranked dividend growth stocks for further research and potential investment. The stocks are ranked based on quality scores, with tie-breaking metrics including dividend safety scores, credit ratings, and forward dividend yield. The top three stocks for this month are Visa, UnitedHealth, and Intercontinental Exchange. The article also provides key metrics and fair value estimates for each stock, and suggests that Tractor Supply Company passes all selection criteria for adding new positions to the author's DivGro portfolio.

10 Dividend Growth Stocks For July 2023

UnitedHealth Group Inc (NYSE: UNH) is up roughly 8.0% on Friday after the managed healthcare company reported a strong second quarter. UnitedHealth shares up on raised outlook Investors are rewarding the stock as UNH raised its full-year guidance as well.

UnitedHealth shares jump 8.0% on strong Q2: analyst still sees significant room to the upside

As of July 14, 2023, UnitedHealth Group Inc ( UNH , Financial) has seen a significant price change of 7.3%, with its stock priced at $480.46. The company's GF Value stands at $548.59, indicating that the stock is modestly undervalued.

UnitedHealth Group (UNH): An In-depth Analysis of its Modest Undervaluation

UnitedHealth Group Inc ( UNH , Financial), one of the largest private health insurers worldwide, has recently seen a 7.85% change in its stock price, currently trading at $482.92. With a GF Value of $548.59, the company appears to be modestly undervalued, indicating potential for higher future returns.

UnitedHealth Group (UNH): A Modestly Undervalued Investment Opportunity

UnitedHealth Group Inc ( UNH , Financial) has recently been showing signs of being modestly undervalued, based on GuruFocus Value calculations. The company's stock, currently trading at $482.92 per share, with a market capitalization of $449.6 billion, is believed to be trading below its intrinsic worth.

UnitedHealth Group (UNH): A Modestly Undervalued Healthcare Behemoth

The results eased investor concerns after UnitedHealth Group flagged a surge in demand for non-urgent surgeries and outpatient services last month.

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

Shares of UnitedHealth Group Inc. UNH, +7.28% are single-handedly keeping the Dow Jones Industrial Average DJIA, +0.38% in positive territory, as they surged 7.2% in afternoon trading in the wake of the health insurer's better-than-expected second-quarter earnings and full-year outlook. The stock's price gain of $32.07, is the second-best since it went public in October 1984, behind only the record $33.21 rally seen on Nov. 4, 2020.

UnitedHealth stock is adding more than 200 points to the Dow's price

UnitedHealth Group's (UNH) Q2 results benefited on the back of solid contributions from the UnitedHealthcare and Optum segments. Management presently forecasts adjusted net EPS within $24.70-$25.00 for 2023.

UnitedHealth Group (UNH) Q2 Earnings Beat, Boosts '23 EPS View

UnitedHealth Group Inc ( UNH , Financial), one of the world's largest private health insurers, has been attracting significant attention from investors. On July 14, 2023, the company's stock price rose by 7.8%, reaching $482.69.

UnitedHealth Group: A Modestly Undervalued Powerhouse in the Health Insurance Industry

News for UnitedHealth Group Stock (UNH)